Generation of dual specific bivalent BiTEs (dbBIspecific T-cell engaging antibodies) for cellular immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Generation of dual specific bivalent BiTEs (dbBIspecific T-cell engaging antibodies) for cellular immunotherapy ; volume:19 ; number:1 ; day:5 ; month:9 ; year:2019 ; pages:1-14 ; date:12.2019
BMC cancer ; 19, Heft 1 (5.9.2019), 1-14, 12.2019
- Creator
-
Kujawski, Maciej
Li, Lin
Bhattacharya, Supriyo
Wong, Patty
Lee, Wen-Hui
Williams, Lindsay
Li, Harry
Chea, Junie
Poku, Kofi
Bowles, Nicole
Vaidehi, Nagarajan
Yazaki, Paul
Shively, John E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-6056-8
- URN
-
urn:nbn:de:101:1-2020012220135192957965
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kujawski, Maciej
- Li, Lin
- Bhattacharya, Supriyo
- Wong, Patty
- Lee, Wen-Hui
- Williams, Lindsay
- Li, Harry
- Chea, Junie
- Poku, Kofi
- Bowles, Nicole
- Vaidehi, Nagarajan
- Yazaki, Paul
- Shively, John E.
- SpringerLink (Online service)
Other Objects (12)
Structural design of tetravalent T-cell engaging bispecific antibodies: improve developability by engineering disulfide bonds
Molecular insights into recognition of GUCY2C by T-cell engaging bispecific antibody anti-GUCY2CxCD3
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
CD3-engaging bispecific antibodies trigger a paracrine regulated wave of T-cell recruitment for effective tumor killing
Evaluation of Bispecific T-Cell Engagers Targeting Murine Cytomegalovirus
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab
Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies
GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma
Love Bites
Soul bites
Magic bites
Structural design of tetravalent T-cell engaging bispecific antibodies: improve developability by engineering disulfide bonds
Molecular insights into recognition of GUCY2C by T-cell engaging bispecific antibody anti-GUCY2CxCD3
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
CD3-engaging bispecific antibodies trigger a paracrine regulated wave of T-cell recruitment for effective tumor killing
Evaluation of Bispecific T-Cell Engagers Targeting Murine Cytomegalovirus
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab
Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies
GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma
Love Bites
Soul bites
Magic bites
Structural design of tetravalent T-cell engaging bispecific antibodies: improve developability by engineering disulfide bonds
Molecular insights into recognition of GUCY2C by T-cell engaging bispecific antibody anti-GUCY2CxCD3
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
CD3-engaging bispecific antibodies trigger a paracrine regulated wave of T-cell recruitment for effective tumor killing
Evaluation of Bispecific T-Cell Engagers Targeting Murine Cytomegalovirus
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab
Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies
GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma
Love Bites
Soul bites